Handling the therapeutic response from the tumor with PET;Manejando la respuesta terapéutica del tumor con PET

Revista Espanola de Medicina Nuclear

Volumn 29, Issue 5, 2010, Pages 273-274

  Baena Canada J M ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CLASSIFICATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; NOTE; POSITRON EMISSION TOMOGRAPHY; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG MONITORING; EVALUATION STUDIES AS TOPIC; HUMANS; INFECTION; INFLAMMATION; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PUBLISHING; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77956619721     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/j.remn.2010.07.001     Document Type: Note

References (19)

1. Francis R.J., Byrne M.J., van der Schaaf A.A., Boucek J.A., Nowak A.K., Phillips M., et al. Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans. J Nucl Med 2007, 48:1449-1458.
2. De Gaetano A.M., Calcagni M.L., Rufini V., Valenza V., Giordano A., Bonomo L. Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls. Abdom Imaging 2009, 34:391-402.
3. Prakash P., Kaira M.K., Sharma A., Shepard J.A., Digumarthy S.R. FDG PET/TC in assessment of pulmonary lymphangitic carcinomatosis. AM J Roentgenol 2010, 194:231-236.
4. Doot R.K., Muzi M., Peterson L.M., Schubert E.K., Gralow J.R., Spetch J.M., et al. Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases. J Nucl Med 2010, 51:521-527.
5. Spies P.E., Kassouf W., Brown G.A., Kamat A.M., Liu P., Gómez J.A., et al. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol 2007, 177:1330-1334.
6. Cheson B.D., Pfistner B., Juweid M.E., Gascoyne R.D., Specht L., Horning S.J., et al. Revised Response Criteria for Malignant Lymphoma. J Clin Oncol 2007, 25:579-586.
7. Pfannenberg C., Aschoff P., Dittmann H., Mayer F., Reischi G., von Weyhern C., et al. PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?. J Nucl Med 2010, 51:845-853.
8. Mukherji S.K., Wolf G.T. Evaluation of head and neck squamous cell carcinoma after treatment. Am J Neuroradiol 2003, 24:1743-1746.
9. Daisne J.F., Duprez T., Weynand B., Lonneux M., Hamoir M., Reychler H., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR Imaging, and FDG PET and validation with surgical specimen. Radiology 2004, 233:93-100.
10. El-Maraghi R.H., Eisenhauer E.A. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III. J Clin Oncol 2008, 26:1346-1354.
11. Contractor K.B., Aboagye E.O. Monitoring Predominantly cytostatic treatment response with 18F-FDG PET. J Nucl Med 2009, 50:97S-105S.
12. Avril N., Sassen S., Roylance R. Response to therapy in breast cancer. J Nucl Med 2009, 50(Suppl 1):55S-63S.
13. Rousseau C., Devillers A., Sagan C., Ferrer L., Bridji B., Campio L., et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 2006, 24:5366-5372.
14. Hodgson N.C., Gulenchyn K.Y. Is there a role for positron emission tomography in breast cancer staging?. J Clin Oncol 2008, 26:712-720.
15. Juweid M.E., Cheson B.D. Positron-Emission Tomography and assessment of cancer therapy. N Engl J Med 2006, 354:496-507.
16. Fernández A, Duch J, Flotats A, Camacho V, Estorch M, Carrió I. Evaluación de la respuesta terapéutica y PET/TAC ¿realmente solo importa el tamaño?. Rev Esp Med Nucl 2010, 29:184-188.
17. Moher D., Simera I., Schulz K.F., Hoey J., Altman D.G. Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med 2008, 6:13. doi:10.1186/1741-7015-6-13. Published online 2008.
18. Maziak D.E., Darling G.E., Inculet R.I., Gulenchyn K.Y., Driedger A.A., Ung Y.C., et al. Positron Emission Tomography in staging early lung cancer: A randomized trial. Ann Intern Med 2009, 151:221-228.
19. Ontario Clinical Oncology Group. Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial). (Consultado el 03/07/2010). Disponible en: http://clinicaltrials.gov/ct2/show/NCT00147472.